Levetiracetam
Product Images NDC 67296-1486

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 67296-1486). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Leveannora1000mg30scount (Leveannora1000mg30scount)

Label for Levetiracetam Tablets USP 1000 mg by Camber Pharmaceuticals, Inc., showing NDC 31722-539-30. The label indicates a bottle containing 30 film-coated tablets, with storage instructions and a pharmacist warning. The manufacturer is Annora Pharma Pvt. Ltd., India, for Camber Pharmaceuticals, Inc., Piscataway, NJ.*

FDA Label Image

Leveannora250mg30scount (Leveannora250mg30scount)

Levetiracetam Tablets USP 250 mg label by Camber Pharmaceuticals, Inc. The label displays the active ingredient and strength, package size of 30 tablets, NDC 31722-536-30, and includes pharmacist dispensing instructions and storage information. It also shows a barcode and manufacturer details.*

FDA Label Image

Leveannora500mg30scount (Leveannora500mg30scount)

Levetiracetam Tablets USP 500 mg packaging label from Camber Pharmaceuticals, Inc. The label includes dosing information, pharmacist instructions, storage conditions, and company addresses. The package contains 30 film-coated tablets and is labeled Rx Only. A barcode is visible, along with a clear indication that each tablet contains 500 mg levetiracetam.*

FDA Label Image

Leveannora750mg30scount (Leveannora750mg30scount)

Label for Levetiracetam Tablets USP 750 mg by Camber Pharmaceuticals, Inc., showing packaging for 30 tablets. The label includes dosing cautions, storage instructions, a barcode, and manufacturer details for Camber Pharmaceuticals in Piscataway, NJ, with mention of Annora Pharma Pvt. Ltd., Telangana, India.*

FDA Label Image

Levecamber1000mg30scount (Levecamber1000mg30scount)

Levetiracetam Tablets, USP 1000 mg film-coated tablets packaging label from Camber Pharmaceuticals, Inc. The label includes drug name, strength, quantity of 30 tablets, and instructions for pharmacists regarding dispensing and storage. It also shows U.S. and Indian manufacturing details, a medication guide URL, and multiple barcodes.*

FDA Label Image

Levecamber250mg30scount (Levecamber250mg30scount)

Label for Levetiracetam Tablets USP 250 mg by Redpharm Drug, Inc., showing NDC 31722-536-30. The label includes instructions for pharmacists, dosage storage conditions, and manufacturer information. The package contains 30 tablets and is marked Rx Only. The label also features a barcode and an area marked '40 x 30 mm Un Varnish Area.'*

FDA Label Image

Levecamber500mg30scount (Levecamber500mg30scount)

Label for Levetiracetam Tablets, USP 500 mg by Camber Pharmaceuticals, Inc., showing a 30-tablet package. The label includes storage instructions, pharmacist warnings, manufacturer details, and a barcode. The labeler indicated is Redpharm Drug, Inc., but the manufacturer named on the label is Camber Pharmaceuticals, Inc.*

FDA Label Image

Levecamber750mg30scount (Levecamber750mg30scount)

Packaging label for Levetiracetam Tablets USP 750 mg by Camber Pharmaceuticals, Inc., showing product strength and form as film-coated tablets. The label includes warnings for pharmacists, storage instructions at 20° to 25°C, and mentions a medication guide URL. It indicates a 30-tablet quantity and lists Camber Pharmaceuticals in Piscataway, NJ, as the manufacturer. Barcodes and NDC 31722-538-30 are visible.*

FDA Label Image

Levecamberlogo1 (Levecamberlogo1)

FDA Label Image

Levefig1 (Levefig1)

A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The chart shows a higher percentage of patients in both Levetiracetam groups compared to Placebo, with specific percentages indicated above each bar.*

FDA Label Image

Levefig2 (Levefig2)

A bar chart comparing the percentage of patients across three groups: Placebo (6.3%), Levetiracetam 1000 mg/day (20.8%), and Levetiracetam 2000 mg/day (35.2%). The chart shows increasing patient percentages with higher doses of Levetiracetam.*

FDA Label Image

Levefig3 (Levefig3)

A bar chart comparing the percentage of patients between two groups: Placebo (N=104) and Levetiracetam 3000 mg/day (N=180). The chart shows approximately 14.4% for the Placebo group and 39.4% for the Levetiracetam group.*

FDA Label Image

Levefig4 (Levefig4)

A bar graph comparing the percentage of patients in two groups: Placebo (N=87) and Levetiracetam (N=101). The Placebo group shows approximately 19.6%, while the Levetiracetam group shows approximately 44.6%. The y-axis represents the percentage of patients.*

FDA Label Image

Levefig5 (Levefig5)

A bar chart comparing the efficacy rates of Placebo and Levetiracetam. The chart shows Levetiracetam with a higher efficacy rate of 72.2% versus 45.2% for Placebo, with sample sizes indicated as 56 for Placebo and 79 for Levetiracetam.*

FDA Label Image

Levefig6 (Levefig6)

A bar graph comparing the efficacy percentages of placebo and Levetiracetam groups. The graph shows around 45.2% efficacy for placebo (N=64) and 72.2% efficacy for Levetiracetam (N=79), with percentages on the y-axis and treatment groups on the x-axis.*

FDA Label Image

Levestructure (Levestructure)

Chemical structure diagram of levetiracetam, illustrating its molecular arrangement with functional groups including an amide and a pyrrolidone ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.